At Praxis, we understand the urgent need for those living with Essential Tremor (ET) to have better treatment options and we are committed to continuing to develop new potential treatment options.  ​

We are excited to inform you that enrollment into the PRAX-944-321 Essential3 study is now open. The Essential3 study is for adults diagnosed with Essential Tremor that have had symptoms for at least 3 years.

If you would like to learn more and see if you may qualify, please visit the study website and complete the online pre-screening assessment. If you pre-qualify, a study staff member will contact you to discuss additional details about participating.

Please sign up below to receive communications from Praxis Precision Medicines about essential tremor and clinical trial updates.

We use cookies to improve your experience and to help us understand how you use our site. Please refer to our cookie notice and privacy statement for more information regarding cookies and other third-party tracking that may be enabled.

For more information on Praxis, including our privacy policy, visit us at If you have any questions, please email us at

© 2023 Praxis Precision Medicines, Inc.

Twitter icon
YouTube icon
LinkedIn icon
Website icon
Facebook icon
Intuit Mailchimp logo